Cargando…
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450989/ https://www.ncbi.nlm.nih.gov/pubmed/36093295 http://dx.doi.org/10.18632/oncotarget.28104 |
| _version_ | 1784784643473539072 |
|---|---|
| author | Mokhtari, Reza Bayat Qorri, Bessi Baluch, Narges Sparaneo, Angelo Fabrizio, Federico Pio Muscarella, Lucia Anna Tyker, Albina Kumar, Sushil Cheng, Hai-Ling Margaret Szewczuk, Myron R. Das, Bikul Yeger, Herman |
| author_facet | Mokhtari, Reza Bayat Qorri, Bessi Baluch, Narges Sparaneo, Angelo Fabrizio, Federico Pio Muscarella, Lucia Anna Tyker, Albina Kumar, Sushil Cheng, Hai-Ling Margaret Szewczuk, Myron R. Das, Bikul Yeger, Herman |
| author_sort | Mokhtari, Reza Bayat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9450989 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94509892022-09-09 Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis Mokhtari, Reza Bayat Qorri, Bessi Baluch, Narges Sparaneo, Angelo Fabrizio, Federico Pio Muscarella, Lucia Anna Tyker, Albina Kumar, Sushil Cheng, Hai-Ling Margaret Szewczuk, Myron R. Das, Bikul Yeger, Herman Oncotarget Correction Impact Journals LLC 2022-08-04 /pmc/articles/PMC9450989/ /pubmed/36093295 http://dx.doi.org/10.18632/oncotarget.28104 Text en Copyright: © 2022 Mokhtari et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Mokhtari, Reza Bayat Qorri, Bessi Baluch, Narges Sparaneo, Angelo Fabrizio, Federico Pio Muscarella, Lucia Anna Tyker, Albina Kumar, Sushil Cheng, Hai-Ling Margaret Szewczuk, Myron R. Das, Bikul Yeger, Herman Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
| title | Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
| title_full | Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
| title_fullStr | Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
| title_full_unstemmed | Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
| title_short | Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
| title_sort | correction: next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the pi3k/akt/mtor survival pathway and inducing apoptosis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450989/ https://www.ncbi.nlm.nih.gov/pubmed/36093295 http://dx.doi.org/10.18632/oncotarget.28104 |
| work_keys_str_mv | AT mokhtarirezabayat correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT qorribessi correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT baluchnarges correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT sparaneoangelo correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT fabriziofedericopio correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT muscarellaluciaanna correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT tykeralbina correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT kumarsushil correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT chenghailingmargaret correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT szewczukmyronr correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT dasbikul correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis AT yegerherman correctionnextgenerationmultimodalityofnutrigenomiccancertherapysulforaphaneincombinationwithacetazolamideactivelytargetbronchialcarcinoidcancerindisablingthepi3kaktmtorsurvivalpathwayandinducingapoptosis |